Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
asunaprevir (196) 196
daclatasvir (179) 179
life sciences & biomedicine (112) 112
science & technology (112) 112
hepatitis c virus (107) 107
hepatitis c (89) 89
humans (80) 80
hepatitis c, chronic - drug therapy (59) 59
gastroenterology & hepatology (55) 55
male (52) 52
middle aged (52) 52
drug therapy, combination (51) 51
genotype (51) 51
female (48) 48
hepatitis (48) 48
hepacivirus - genetics (46) 46
aged (45) 45
antiviral agents - therapeutic use (45) 45
interferon (40) 40
imidazoles - therapeutic use (38) 38
isoquinolines - therapeutic use (37) 37
sulfonamides - therapeutic use (37) 37
health aspects (35) 35
chronic hepatitis c (34) 34
hepacivirus - drug effects (32) 32
hepatitis c, chronic - virology (31) 31
adult (30) 30
antiviral agents - administration & dosage (30) 30
genetic aspects (30) 30
sofosbuvir (30) 30
treatment outcome (30) 30
imidazoles - administration & dosage (29) 29
antiviral agents - adverse effects (28) 28
isoquinolines - administration & dosage (28) 28
ribavirin (28) 28
sulfonamides - administration & dosage (28) 28
sustained virologic response (28) 28
antiviral agents (27) 27
care and treatment (27) 27
liver (25) 25
pharmacology & pharmacy (25) 25
analysis (23) 23
hcv (23) 23
isoquinolines - adverse effects (23) 23
sulfonamides - adverse effects (23) 23
ledipasvir (22) 22
imidazoles - adverse effects (21) 21
liver cirrhosis (21) 21
patients (21) 21
biological response modifiers (20) 20
genotype 1b (18) 18
aged, 80 and over (17) 17
genotype & phenotype (17) 17
simeprevir (17) 17
cirrhosis (15) 15
direct-acting antivirals (15) 15
hepatitis c, chronic - complications (15) 15
virology (15) 15
beclabuvir (14) 14
hemodialysis (14) 14
hepacivirus - isolation & purification (14) 14
hepatitis c - drug therapy (14) 14
medicine & public health (14) 14
original article (14) 14
protease inhibitors (14) 14
proteases (14) 14
viral nonstructural proteins - genetics (14) 14
drug resistance, viral (13) 13
infectious diseases (13) 13
medical research (13) 13
original (13) 13
rna, viral - blood (13) 13
general & internal medicine (12) 12
genotypes (12) 12
hepatology (12) 12
medicine, experimental (12) 12
medicine, general & internal (12) 12
young adult (12) 12
drug resistance (11) 11
drug therapy (11) 11
resistance-associated variants (11) 11
telaprevir (11) 11
treatment failure (11) 11
boceprevir (10) 10
drug resistance, viral - genetics (10) 10
fibrosis (10) 10
hepacivirus - classification (10) 10
japan (10) 10
paritaprevir (10) 10
ribavirin - therapeutic use (10) 10
viral load (10) 10
viral nonstructural proteins - antagonists & inhibitors (10) 10
chronic infection (9) 9
colorectal surgery (9) 9
drug administration schedule (9) 9
gastroenterology (9) 9
infections (9) 9
pharmacokinetics (9) 9
ribonucleic acid--rna (9) 9
safety (9) 9
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (164) 164
Korean (48) 48
Japanese (11) 11
Hungarian (3) 3
Russian (2) 2
Chinese (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Daclatasvir plus asunaprevir dual therapy for chronic HCV genotype 1b infection: Results of Turkish early access program
by Köklü, Seyfettin and Köksal, Iftihar and Akarca, Ulus Salih and Balkan, Ayhan and Güner, Rahmet and Demirezen, Aylin and Sahin, Memduh and Akhan, Sila and Ozaras, Resat and Idilman, Ramazan
Annals of hepatology, ISSN 1665-2681, 01/2017, Volume 16, Issue 1, pp. 71 - 76
Daclatasvir | Asunaprevir | Chronic C hepatitis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text The Real-World Safety and Efficacy of Daclatasvir and Asunaprevir for Elderly Patients
by Shinya Taki and and Hideyuki Tamai and Yoshiyuki Ida and Naoki Shingaki and Akira Kawashima and Ryo Shimizu and Kosaku Moribata and Takao Maekita and Mikitaka Iguchi and Jun Kato and Taisei Nakao and Masayuki Kitano
Gut and liver, ISSN 1976-2283, 01/2018, Volume 12, Issue 1, p. 86
Daclatasvir | Asunaprevir | Hepacivirus | Genotype 1b
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Daclatasvir Plus Asunaprevir for the Treatment of Patients with Hepatitis C Virus Genotype 1b Infection: Real-World Efficacy, Changes in Liver Stiffness and Fibrosis Markers, and Safety
by Hye Won Lee and and Se Rim Oh and Dong Yun Kim and Yechan Jeong and Seungtaek Kim and Beom Kyung Kim and Seung Up Kim and Do Young Kim and Sang Hoon Ahn and Kwang-hyub Han and Jun Yong Park
Gut and liver, ISSN 1976-2283, 05/2018, Volume 12, Issue 3, p. 324
Daclatasvir | Fibrosis | Asunaprevir | Hepatitis C | Genotype 1b
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Daclatasvir Plus Asunaprevir for the Treatment of Patients with Hepatitis C Virus Genotype 1b Infection: Real-World Efficacy, Changes in Liver Stiffness and Fibrosis Markers, and Safety
by Hye Won Lee and and Se Rim Oh and Dong Yun Kim and Yechan Jeong and Seungtaek Kim and Beom Kyung Kim and Seung Up Kim and Do Young Kim and Sang Hoon Ahn and Kwang-hyub Han and Jun Yong Park
Gut and liver, ISSN 1976-2283, 05/2018, Volume 12, Issue 3, p. 324
Daclatasvir | Fibrosis | Asunaprevir | Hepatitis C | Genotype 1b
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Daclatasvir Plus Asunaprevir for the Treatment of Patients with Hepatitis C Virus Genotype 1b Infection: Real-World Efficacy, Changes in Liver Stiffness and Fibrosis Markers, and Safety
by Hye Won Lee and and Se Rim Oh and Dong Yun Kim and Yechan Jeong and Seungtaek Kim and Beom Kyung Kim and Seung Up Kim and Do Young Kim and Sang Hoon Ahn and Kwang-hyub Han and Jun Yong Park
Gut and liver, ISSN 1976-2283, 05/2018, Volume 12, Issue 3, p. 324
Daclatasvir | Fibrosis | Asunaprevir | Hepatitis C | Genotype 1b
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Direct Acting Antiviral Agents in Korean Patients with Chronic Hepatitis C and Hemophilia Who Are Treatment-Naive or Treatment-Experienced
by Hyun Woong Lee and and Ki Young Yoo and Joung Won Won and Hyung Joon Kim
Gut and liver, ISSN 1976-2283, 09/2017, Volume 11, Issue 5, p. 721
chronic; Sofosbuvir; Ledipasvir; Daclatasvir; Asunaprevir | Hepatitis C
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Direct Acting Antiviral Agents in Korean Patients with Chronic Hepatitis C and Hemophilia Who Are Treatment-Naive or Treatment-Experienced
by Hyun Woong Lee and and Ki Young Yoo and Joung Won Won and Hyung Joon Kim
Gut and liver, ISSN 1976-2283, 09/2017, Volume 11, Issue 5, p. 721
Daclatasvir | Ledipasvir | Asunaprevir | Hepatitis C | chronic | Sofosbuvir
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Direct Acting Antiviral Agents in Korean Patients with Chronic Hepatitis C and Hemophilia Who Are Treatment-Naive or Treatment-Experienced
by Hyun Woong Lee and and Ki Young Yoo and Joung Won Won and Hyung Joon Kim
Gut and liver, ISSN 1976-2283, 09/2017, Volume 11, Issue 5, p. 721
Daclatasvir | Ledipasvir | Asunaprevir | Hepatitis C | chronic | Sofosbuvir
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Daclatasvir and asunaprevir combination therapy for patients with chronic hepatitis C virus genotype 1b infection in real world
by Jae Young Oh and and Byung Seok Kim and Chang Hyeong Lee and Jeong Eun Song and Heon Ju Lee and Jung Gil Park and Jae Seok Hwang and Woo Jin Chung and Byoung Kuk Jang and Young Oh Kweon and Won Young Tak and Soo Young Park and Se Young Jang and Jeong Ill Suh and Sang Gyu Kwak
The Korean journal of internal medicine, ISSN 1226-3303, 07/2019, Volume 34, Issue 4, p. 794
Daclatasvir | Real world | Asunaprevir | Hepatitis C | chronic | Genotype 1b
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Asunaprevir
Australian prescriber, ISSN 0312-8008, 04/2016, Volume 39, Issue 2, pp. 58 - 60
asunaprevir | hepatitis C
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Efficacy and Safety of Daclatasvir and Asunaprevir in Patients with Hepatitis C Virus Genotype 1b Infection on Hemodialysis
by Byung Seok Lee and and Myeong Jun Song and Jung Hyun Kwon and Tae Hee Lee and Ji Woong Jang and Seok Hyun Kim and Sae Hwan Lee and Hong Soo Kim and Ji Hoon Kim and Seok Bae Kim and Soon Young Ko and Do Seon Song
Gut and liver, ISSN 1976-2283, 03/2019, Volume 13, Issue 2, p. 191
Daclatasvir | Chronic hepatitis C virus | Hemodialysis | Asunaprevir | Sustained virologic response
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Efficacy and Safety of Daclatasvir and Asunaprevir in Patients with Hepatitis C Virus Genotype 1b Infection on Hemodialysis
by Byung Seok Lee and and Myeong Jun Song and Jung Hyun Kwon and Tae Hee Lee and Ji Woong Jang and Seok Hyun Kim and Sae Hwan Lee and Hong Soo Kim and Ji Hoon Kim and Seok Bae Kim and Soon Young Ko and Do Seon Song
Gut and liver, ISSN 1976-2283, 03/2019, Volume 13, Issue 2, p. 191
Daclatasvir | Chronic hepatitis C virus | Hemodialysis | Asunaprevir | Sustained virologic response
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Efficacy and safety of daclatasvir plus asunaprevir for Korean patients with HCV genotype Ib infection: a retrospective multi-institutional study
by Byeong Wook Cho and and Seok Bae Kim and Il Han Song and Sae Hwan Lee and Hong Soo Kim and Tae Hee Lee and Young Woo Kang and Seok Hyun Kim and Byung Seok Lee and Hee Bok Chae
Clinical and molecular hepatology, ISSN 2287-2728, 03/2017, Volume 23, Issue 1, p. 51
Chronic; Korea | Daclatasvir; Asunaprevir; Hepatitis C
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment options
by Suzuki, Yoshiyuki and Ikeda, Kenji and Suzuki, Fumitaka and Toyota, Joji and Karino, Yoshiyasu and Chayama, Kazuaki and Kawakami, Yoshiiku and Ishikawa, Hiroki and Watanabe, Hideaki and Hu, Wenhua and Eley, Timothy and McPhee, Fiona and Hughes, Eric and Kumada, Hiromitsu
Journal of hepatology, ISSN 0168-8278, 2012, Volume 58, Issue 4, pp. 655 - 662
Gastroenterology and Hepatology | Daclatasvir | Antiviral | Asunaprevir | Hepatitis C | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Isoquinolines - adverse effects | Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Imidazoles - administration & dosage | Male | RNA, Viral - blood | Treatment Failure | Adult | Female | Drug Therapy, Combination | Hepacivirus - drug effects | Administration, Oral | Imidazoles - adverse effects | Genotype | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Antiviral Agents - adverse effects | Sulfonamides - adverse effects | Aged | Hepacivirus - classification | Isoquinolines - administration & dosage | Sulfonamides - administration & dosage | Care and treatment | Genetic aspects | Hepatitis C virus | Health aspects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text HCV direct‐acting antiviral agents: the best interferon‐free combinations
by Schinazi, Raymond and Halfon, Philippe and Marcellin, Patrick and Asselah, Tarik
Liver international, ISSN 1478-3223, 02/2014, Volume 34, Issue 1, pp. 69 - 78
sofosbuvir | faldaprevir | ribavirin | simeprevir | pegylated interferon | asunaprevir | daclatasvir | Daclatasvir | Simeprevir | Pegylated interferon | Faldaprevir | Asunaprevir | Ribavirin | Sofosbuvir | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Heterocyclic Compounds, 3-Ring | Hepatitis C - drug therapy | Oligopeptides | Isoquinolines | Humans | Hepacivirus - genetics | Drug Discovery - methods | Disease Eradication - methods | Recombinant Proteins | Protease Inhibitors - pharmacology | Thiazoles | Hepacivirus - drug effects | Virus Replication - drug effects | Antiviral Agents - pharmacology | Polyethylene Glycols | Antiviral Agents - therapeutic use | Interferon-alpha | Clinical Trials as Topic | Disease Eradication - trends | Drug Therapy, Combination - methods | Drug Therapy, Combination - trends | Imidazoles | Sulfonamides | Uridine Monophosphate - analogs & derivatives | Viral Nonstructural Proteins - antagonists & inhibitors | Virus Replication - physiology | Hepatitis C virus | Biological response modifiers | Interferon | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text HCV genotype 1-6 NS3 residue 80 substitutions impact protease inhibitor activity and promote viral escape
by Pham, Long V and Jensen, Sanne Brun and Fahnøe, Ulrik and Pedersen, Martin Schou and Tang, Qi and Ghanem, Lubna and Ramirez, Santseharay and Humes, Daryl and Serre, Stéphanie B.N and Schønning, Kristian and Bukh, Jens and Gottwein, Judith M
Journal of hepatology, ISSN 0168-8278, 03/2019, Volume 70, Issue 3, pp. 388 - 397
Resistance | Simeprevir | Voxilaprevir, Hepatitis C virus | Glecaprevir | Direct-acting antiviral | Q80K | Resistance associated substitutions | Paritaprevir | Asunaprevir | Linkage analysis | Grazoprevir | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Full Text Efficacy and safety of daclatasvir and asunaprevir combination therapy in chronic hemodialysis patients with chronic hepatitis C
by Suda, Goki and Kudo, Mineo and Nagasaka, Atsushi and Furuya, Ken and Yamamoto, Yoshiya and Kobayashi, Tomoe and Shinada, Keisuke and Tateyama, Miki and Konno, Jun and Tsukuda, Yoko and Yamasaki, Kazushi and Kimura, Megumi and Umemura, Machiko and Izumi, Takaaki and Tsunematsu, Seiji and Sato, Fumiyuki and Terashita, Katsumi and Nakai, Masato and Horimoto, Hiromasa and Sho, Takuya and Natsuizaka, Mitsuteru and Morikawa, Kenichi and Ogawa, Koji and Sakamoto, Naoya
Journal of gastroenterology, ISSN 0944-1174, 7/2016, Volume 51, Issue 7, pp. 733 - 740
Daclatasvir | Medicine & Public Health | Colorectal Surgery | Hemodialysis | Hepatology | Gastroenterology | Abdominal Surgery | HCV | Asunaprevir | Surgical Oncology | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Prospective Studies | Antiviral Agents - therapeutic use | Humans | Middle Aged | Male | Hepatitis C, Chronic - complications | Hepatitis C, Chronic - drug therapy | Renal Insufficiency - therapy | Sulfonamides - therapeutic use | Isoquinolines - therapeutic use | Female | Renal Insufficiency - complications | Aged | Imidazoles - therapeutic use | Drug Therapy, Combination | Renal Dialysis | Evaluation | Care and treatment | Proteases | Liver | Hepatitis C | Hepatitis C virus | Liver cirrhosis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
18. Full Text Characterization of virologic escape in hepatitis C virus genotype 1b patients treated with the direct-acting antivirals daclatasvir and asunaprevir
by Karino, Yoshiyasu and Toyota, Joji and Ikeda, Kenji and Suzuki, Fumitaka and Chayama, Kazuaki and Kawakami, Yoshiiku and Ishikawa, Hiroki and Watanabe, Hideaki and Hernandez, Dennis and Yu, Fei and McPhee, Fiona and Kumada, Hiromitsu
Journal of hepatology, ISSN 0168-8278, 2012, Volume 58, Issue 4, pp. 646 - 654
Gastroenterology and Hepatology | Daclatasvir | Asunaprevir | Drug resistance | Hepatitis C | Peginterferon-sparing | Direct-acting antivirals | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Hepacivirus - drug effects | Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Imidazoles - administration & dosage | Viral Nonstructural Proteins - genetics | Genotype | Male | RNA, Viral - blood | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Polymorphism, Genetic | Drug Resistance, Viral - genetics | Treatment Failure | Genes, Viral | Adult | Female | Aged | Hepacivirus - classification | Drug Therapy, Combination | Isoquinolines - administration & dosage | Sulfonamides - administration & dosage | Virus diseases | Antiviral agents | Care and treatment | Proteases | Biological products industry | Genetic aspects | Chemical properties | Hepatitis C virus | Health aspects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
19. Full Text Limitations of daclatasvir/asunaprevir plus beclabuvir treatment in cases of NS5A inhibitor treatment failure
by Teraoka, Yuji and Uchida, Takuro and Imamura, Michio and Hiraga, Nobuhiko and Osawa, Mitsutaka and Kan, Hiromi and Saito, Yuhei and Tsuge, Masataka and Abe-Chayama, Hiromi and Hayes, C. Nelson and Makokha, Grace Naswa and Aikata, Hiroshi and Miki, Daiki and Ochi, Hidenori and Ishida, Yuji and Tateno, Chise and Chayama, Kazuaki
Journal of general virology, ISSN 0022-1317, 08/2018, Volume 99, Issue 8, pp. 1058 - 1065
Daclatasvir | Beclabuvir | RAV | Treatment failures | Asunaprevir | HCV | Human hepatocyte chimeric mouse | Life Sciences & Biomedicine | Biotechnology & Applied Microbiology | Science & Technology | Virology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
20. Full Text Effectiveness and safety of daclatasvir plus asunaprevir for patients with hepatitis C virus genotype 1b aged 75 years and over with or without cirrhosis
by Ogawa, Eiichi and Furusyo, Norihiro and Yamashita, Naoki and Kawano, Akira and Takahashi, Kazuhiro and Dohmen, Kazufumi and Nakamuta, Makoto and Satoh, Takeaki and Nomura, Hideyuki and Azuma, Koichi and Koyanagi, Toshimasa and Kotoh, Kazuhiro and Shimoda, Shinji and Kajiwara, Eiji and Hayashi, Jun and Kyushu University Liver Disease Study(KULDS) Group
Hepatology research, ISSN 1386-6346, 03/2017, Volume 47, Issue 3, pp. E120 - E131
hepatitis C virus | asunaprevir | elderly | cirrhosis | daclatasvir | Care and treatment | Safety and security measures | Protease inhibitors | Proteases | Analysis | Interferon | Genetic aspects | Biological response modifiers | Hepatitis C virus | Health aspects | Liver cirrhosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.